Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1968 1
1970 1
1971 1
1973 2
1974 1
1975 1
1982 2
1985 1
1986 1
1989 6
1990 1
1991 4
1992 4
1993 3
1994 7
1995 10
1996 7
1997 4
1998 17
1999 13
2000 20
2001 12
2002 17
2003 21
2004 10
2005 14
2006 8
2007 10
2008 18
2009 17
2010 14
2011 14
2012 23
2013 29
2014 40
2015 33
2016 23
2017 44
2018 21
2019 27
2020 39
2021 9
Text availability
Article attribute
Article type
Publication date

Search Results

499 results
Results by year
Filters applied: . Clear all
Page 1
Receptor Tyrosine Kinase-Targeted Cancer Therapy.
Yamaoka T, Kusumoto S, Ando K, Ohba M, Ohmori T. Yamaoka T, et al. Int J Mol Sci. 2018 Nov 6;19(11):3491. doi: 10.3390/ijms19113491. Int J Mol Sci. 2018. PMID: 30404198 Free PMC article. Review.
Brigatinib and Alectinib for ALK Rearrangement-Positive Advanced Non-Small Cell Lung Cancer With or Without Central Nervous System Metastasis: A Systematic Review and Network Meta-Analysis.
Ando K, Akimoto K, Sato H, Manabe R, Kishino Y, Homma T, Kusumoto S, Yamaoka T, Tanaka A, Ohmori T, Sagara H. Ando K, et al. Among authors: yamaoka t. Cancers (Basel). 2020 Apr 10;12(4):942. doi: 10.3390/cancers12040942. Cancers (Basel). 2020. PMID: 32290309 Free PMC article. Review.
Assessing the association between optimal energy intake and all-cause mortality in older patients with diabetes mellitus using the Japanese Elderly Diabetes Intervention Trial.
Omura T, Tamura Y, Yamaoka T, Yoshimura Y, Sakurai T, Umegaki H, Kamada C, Iimuro S, Ohashi Y, Ito H, Araki A; Japanese Elderly Diabetes Intervention Trial Research Group. Omura T, et al. Among authors: yamaoka t. Geriatr Gerontol Int. 2020 Jan;20(1):59-65. doi: 10.1111/ggi.13820. Epub 2019 Dec 10. Geriatr Gerontol Int. 2020. PMID: 31820841 Free PMC article. Clinical Trial.
KRAS and EGFR Amplifications Mediate Resistance to Rociletinib and Osimertinib in Acquired Afatinib-Resistant NSCLC Harboring Exon 19 Deletion/T790M in EGFR.
Nakatani K, Yamaoka T, Ohba M, Fujita KI, Arata S, Kusumoto S, Taki-Takemoto I, Kamei D, Iwai S, Tsurutani J, Ohmori T. Nakatani K, et al. Among authors: yamaoka t. Mol Cancer Ther. 2019 Jan;18(1):112-126. doi: 10.1158/1535-7163.MCT-18-0591. Epub 2018 Oct 15. Mol Cancer Ther. 2019. PMID: 30322949 Free article.
Discovery of BMS-986235/LAR-1219: A Potent Formyl Peptide Receptor 2 (FPR2) Selective Agonist for the Prevention of Heart Failure.
Asahina Y, Wurtz NR, Arakawa K, Carson N, Fujii K, Fukuchi K, Garcia R, Hsu MY, Ishiyama J, Ito B, Kick E, Lupisella J, Matsushima S, Ohata K, Ostrowski J, Saito Y, Tsuda K, Villarreal F, Yamada H, Yamaoka T, Wexler R, Gordon D, Kohno Y. Asahina Y, et al. Among authors: yamaoka t. J Med Chem. 2020 Sep 10;63(17):9003-9019. doi: 10.1021/acs.jmedchem.9b02101. Epub 2020 May 24. J Med Chem. 2020. PMID: 32407089
[Amidophosphoribosyltransferase].
Hino S, Yamaoka T. Hino S, et al. Among authors: yamaoka t. Nihon Rinsho. 2003 Jan;61 Suppl 1:24-30. Nihon Rinsho. 2003. PMID: 12629686 Review. Japanese. No abstract available.
Magnetic-Pole Flip by Millimeter Wave.
Ohkoshi SI, Yoshikiyo M, Imoto K, Nakagawa K, Namai A, Tokoro H, Yahagi Y, Takeuchi K, Jia F, Miyashita S, Nakajima M, Qiu H, Kato K, Yamaoka T, Shirata M, Naoi K, Yagishita K, Doshita H. Ohkoshi SI, et al. Among authors: yamaoka t. Adv Mater. 2020 Dec;32(48):e2004897. doi: 10.1002/adma.202004897. Epub 2020 Oct 8. Adv Mater. 2020. PMID: 33029839
499 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page